Fowler Neal Franklin (CIK 1493692) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-04). Recent activity: Buy EBS (25,344 shares), Buy EBS (34,403 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-04 | Emergent BioSolutions Inc. (EBS) | Director | Buy | 25,344 | $0 |
| 2025-05-02 | Emergent BioSolutions Inc. (EBS) | Director | Buy | 34,403 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-04